This session reviews the AUA Guidelines for Early Detection of Prostate Cancer, including screening recommendations, use of PSA and other biomarkers, use of MRI for prostate cancer detection, and safe biopsy practices.

Continuing Education Instructions and Disclosure Information:

Contact hours available until 3/3/26.

Requirements for Successful Completion:
Complete the learning activity in its entirety and complete the online nursing continuing professional development evaluation. You will be able to print your NCPD certificate at any time after you complete the evaluation.

Disclosure of relevant financial relationships with ineligible companies (planners, faculty/speakers, reviewers):

Planning Committee Disclosures:
There are no Planning Committee disclosures to declare.

Speaker Disclosures:
Daniel Barocas
Ad Board Participant - Pacific Edge, Lantheus, Astellas/Pfizer, Lynx Dx
Consultant - Boehringer-Ingelheim

Commercial Support:
No commercial support declared.

Accreditation Statement:
The Society of Urologic Nurses and Associates (SUNA) is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.

SUNA accreditation is reciprocal in the states and specialty organizations that recognize the ANCC-COA accreditation process. SUNA is an approved provider of continuing nursing education by the California Board of Registered Nursing, Provider Number CEP 5556. Accreditation and approved provider status of NCPD does not imply ANCC-COA approval or endorsement of any product, advertising, or educational content. SUNA urges all participants to be aware of the requirements for re-licensure in the states in which they hold a license.

Learning Outcome:
After completing this learning activity, the participant will be able to apply the AUA Guidelines for Early Detection of Prostate Cancer.

Credits Available